Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (VGSCs or NaV channels) are essential transmembrane proteins that enable the rapid influx of sodium ions (Na⁺) into excitable cells, such as neurons, muscle cells, and cardiac myocytes. This influx is critical for the initiation and propagation of action potentials—electrical signals that underlie nerve impulses, muscle contraction, and heartbeats. The core functional unit is a large alpha (α) subunit which forms the ion-conducting pore. Accessory beta (β) subunits associate with α subunits to modulate channel kinetics, voltage dependence, localization, and cell-surface expression. There are multiple VGSC isoforms encoded by different genes (e.g., SCN1A-SCN11A), each subtype has unique gating properties suited to its physiological context. Mutations or dysregulation can cause diseases such as epilepsy, chronic pain syndromes, periodic paralysis disorders, or cardiac arrhythmias. VGSCs are major drug targets.
Drugs block the channel pore or modify gating behavior, preventing Na⁺ influx and inhibiting action potential generation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-Gated Sodium Channel (VGSC).